PL2117520T3
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
Abstract
This record has no abstract on file.
Term
1.2 yearsto projected expiry
Projected expiry 14 December 2027, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
11 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11
32 members in 15 offices
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 87500406 | United States of America | P | |
| 87500406 | United States of America | P | |
| 07862937 | European Patent Office (EPO) | A | |
| 2007025645 | United States of America | W | |
| 2007025645 | United States of America | W | |
| 078629375 | – | – | – |
| 875004P | – | – | – |
| EP20070862937 | – | – | – |
| US20060875004P | – | – | – |
| WO2007US25645 | – | – | – |
Members32
| Document | Office | Kind | |
|---|---|---|---|
| US952035A | United States of America | A | |
| AU2007334360A1 | Australia | A1 | |
| CA2672618A1 | Canada | A1 | |
| WO2008076373A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP2117520A1 | European Patent Office (EPO) | A1 | |
| CN101605535A | China | A | |
| US2010048499A1 | United States of America | A1 | |
| JP2010513284A | Japan | A | |
| AU2007334360B2 | Australia | B2 | |
| US2013280337A1 | United States of America | A1 | |
| JP2014080443A | Japan | A | |
| US8999396B2 | United States of America | B2 | |
| CN104586815A | China | A | |
| US2015313866A1 | United States of America | A1 | |
| JP2016020398A | Japan | A | |
| HK1210045A | Hong Kong, China | A | |
| HK1210045A1 | Hong Kong, China | A1 | |
| JP5933893B2 | Japan | B2 | |
| US9675578B2 | United States of America | B2 | |
| US9724323B2 | United States of America | B2 | |
| US2017340599A1 | United States of America | A1 | |
| EP2117520B1 | European Patent Office (EPO) | B1 | |
| PT2117520T | Portugal | T | |
| LT2117520T | Lithuania | T | |
| DK2117520T3 | Denmark | T3 | |
| SI2117520T1 | Slovenia | T1 | |
| ES2700074T3 | Spain | T3 | |
| PL2117520T3This record | Poland | T3 | |
| EP3470071A1 | European Patent Office (EPO) | A1 | |
| CY1121200T1 | Cyprus | T1 | |
| US10682420B2 | United States of America | B2 | |
| CA2672618C | Canada | C |
Numbers
- Publication
- 2117520
- Publication, DOCDB
- 2117520
- Publication, EPODOC
- PL2117520T
- Application
- 7862937
- Application, DOCDB
- 07862937
- Application, EPODOC
- PL20070862937T
Titles2
- English
- BREAST CANCER THERAPY BASED ON HORMONE RECEPTOR STATUS WITH NANOPARTICLES COMPRISING TAXANE
- Polish
- TERAPIA RAKA PIERSI W OPARCIU O STATUS WYSTĘPOWANIA RECEPTORA HORMONALNEGO PRZY UŻYCIU NANOCZĄSTEK ZAWIERAJĄCYCH TAKSAN
Classification
- CPC, 18
- A61K47/643
- A61K31/337
- A61K9/0019
- A61K9/5169
- A61K47/42
- A61P35/00
- A61K31/704
- A61K31/7068
- A61K31/282
- A61K31/475
- A61K31/5377
- A61K31/513
- A61K31/664
- A61K31/505
- A61K31/661
- A61K31/7034
- A61K39/39558
- A61K47/64
- IPC, 4
- A61K9 51
- A61K31 337
- A61K47 42
- A61P35 00